{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:08:44Z","timestamp":1767035324610,"version":"3.48.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04333-x","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T19:23:36Z","timestamp":1766431416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GRB10 as a pan-cancer biomarker linking oncogenic signaling, immunosuppression, and immunotherapy resistance"],"prefix":"10.1007","volume":"16","author":[{"given":"Haoran","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"3","key":"4333_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4333_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/10408360902937809","volume":"46","author":"CN Baxevanis","year":"2009","unstructured":"Baxevanis CN, Perez SA, Papamichail M. Cancer immunotherapy. Crit Rev Clin Lab Sci. 2009;46(4):167\u201389.","journal-title":"Crit Rev Clin Lab Sci"},{"doi-asserted-by":"crossref","unstructured":"Cha JH, Chan LC, Song MS et al. New approaches on cancer immunotherapy. Cold Spring Harb Perspect Med, 2020; 10(8).","key":"4333_CR3","DOI":"10.1101\/cshperspect.a036863"},{"key":"4333_CR4","doi-asserted-by":"publisher","first-page":"104588","DOI":"10.1016\/j.critrevonc.2024.104588","volume":"206","author":"CY Hsu","year":"2024","unstructured":"Hsu CY, Pallathadka H, Jasim SA, et al. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions. Crit Rev Oncol Hematol. 2024;206:104588.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"4333_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/jcp.10363","volume":"197","author":"A Morrione","year":"2003","unstructured":"Morrione A. Grb10 adapter protein as regulator of insulin-like growth factor receptor signaling. J Cell Physiol. 2003;197(3):307\u201311.","journal-title":"J Cell Physiol"},{"issue":"44","key":"4333_CR6","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1038\/sj.onc.1204775","volume":"20","author":"DC Han","year":"2001","unstructured":"Han DC, Shen TL, Guan JL. The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene. 2001;20(44):6315\u201321.","journal-title":"Oncogene"},{"issue":"12","key":"4333_CR7","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.1074\/jbc.273.12.6860","volume":"273","author":"W He","year":"1998","unstructured":"He W, Rose DW, Olefsky JM, et al. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains. J Biol Chem. 1998;273(12):6860\u20137.","journal-title":"J Biol Chem"},{"issue":"9","key":"4333_CR8","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.18632\/aging.204603","volume":"15","author":"LL Ren","year":"2023","unstructured":"Ren LL, Wang ZW, Sen R, et al. GRB10 is a novel factor associated with gastric cancer proliferation and prognosis. Aging. 2023;15(9):3394\u2013409.","journal-title":"Aging"},{"issue":"1","key":"4333_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s10020-023-00722-6","volume":"29","author":"Z Wei","year":"2023","unstructured":"Wei Z, Xia K, Zheng D, et al. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated Inhibition of the PI3K\/AKT\/mTOR pathway. Mol Med. 2023;29(1):133.","journal-title":"Mol Med"},{"issue":"2","key":"4333_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ijc.33335","volume":"148","author":"J Hao","year":"2021","unstructured":"Hao J, Ci X, Wang Y, et al. GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells. Int J Cancer. 2021;148(2):469\u201380.","journal-title":"Int J Cancer"},{"issue":"1","key":"4333_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41065-024-00330-2","volume":"161","author":"Y Yu","year":"2024","unstructured":"Yu Y, Shang Y, Shi S, et al. Combination of arsenic trioxide and apatinib synergistically inhibits small cell lung cancer by down-regulating VEGFR2\/mTOR and Akt\/c-Myc signaling pathway via GRB10. Hereditas. 2024;161(1):29.","journal-title":"Hereditas"},{"issue":"3","key":"4333_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.molonc.2012.11.003","volume":"7","author":"JU Kazi","year":"2013","unstructured":"Kazi JU, Ronnstrand L. FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia. Mol Oncol. 2013;7(3):402\u201318.","journal-title":"Mol Oncol"},{"issue":"6","key":"4333_CR13","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.7150\/thno.70744","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Wang R, Jiang K, et al. PINCH-1 promotes IGF-1 receptor expression and skin cancer progression through Inhibition of the GRB10-NEDD4 complex. Theranostics. 2022;12(6):2613\u201330.","journal-title":"Theranostics"},{"issue":"1","key":"4333_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12935-022-02636-5","volume":"22","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tang M, Xiong J, et al. GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma. Cancer Cell Int. 2022;22(1):223.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4333_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/bib\/bbz046","volume":"21","author":"F Li","year":"2020","unstructured":"Li F, Wu T, Xu Y, et al. A comprehensive overview of oncogenic pathways in human cancer. Brief Bioinform. 2020;21(3):957\u201369.","journal-title":"Brief Bioinform"},{"issue":"9","key":"4333_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s43018-021-00250-4","volume":"2","author":"F Chen","year":"2021","unstructured":"Chen F, Wendl MC, Wyczalkowski MA, et al. Moving pan-cancer studies from basic research toward the clinic. Nat Cancer. 2021;2(9):879\u201390.","journal-title":"Nat Cancer"},{"issue":"7","key":"4333_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/cac2.70008","volume":"45","author":"X Cen","year":"2025","unstructured":"Cen X, Lan Y, Zou J, et al. Pan-cancer analysis shapes the Understanding of cancer biology and medicine. Cancer Commun (Lond). 2025;45(7):728\u201346.","journal-title":"Cancer Commun (Lond)"},{"key":"4333_CR18","doi-asserted-by":"publisher","first-page":"1521238","DOI":"10.3389\/fgene.2024.1521238","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Han W, Zhang X, et al. Depression-related innate immune genes and pan-cancer gene analysis and validation. Front Genet. 2024;15:1521238.","journal-title":"Front Genet"},{"issue":"8","key":"4333_CR19","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4333_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","volume":"132","author":"A Pellagatti","year":"2018","unstructured":"Pellagatti A, Armstrong RN, Steeples V, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations. Blood. 2018;132(12):1225\u201340.","journal-title":"Blood"},{"issue":"14","key":"4333_CR21","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a Bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics. 2007;23(14):1846\u20137.","journal-title":"Bioinformatics"},{"issue":"7","key":"4333_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"doi-asserted-by":"crossref","unstructured":"Liu Z, Liu L, Weng S et al. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data, 2023; 10(1).","key":"4333_CR23","DOI":"10.1186\/s40537-023-00844-y"},{"issue":"W1","key":"4333_CR24","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4333_CR25","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"6","key":"4333_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"key":"4333_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"4333_CR28","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"4333_CR29","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, et al. IOBR: Multi-Omics Immuno-Oncology biological research to Decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"issue":"11","key":"4333_CR30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"issue":"5","key":"4333_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"6","key":"4333_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39(6):845\u201365. e7.","journal-title":"Cancer Cell"},{"key":"4333_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395\u2013412.","journal-title":"Annu Rev Pathol"},{"issue":"Pt 2","key":"4333_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20050216","volume":"388","author":"LJ Holt","year":"2005","unstructured":"Holt LJ, Siddle K. Grb10 and Grb14: enigmatic regulators of insulin action\u2013and more? Biochem J. 2005;388(Pt 2):393\u2013406.","journal-title":"Biochem J"},{"issue":"3","key":"4333_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.coi.2011.01.005","volume":"23","author":"N Engels","year":"2011","unstructured":"Engels N, Wienands J. The signaling tool box for tyrosine-based costimulation of lymphocytes. Curr Opin Immunol. 2011;23(3):324\u20139.","journal-title":"Curr Opin Immunol"},{"doi-asserted-by":"crossref","unstructured":"Wen L, Hu W, Hou S et al. GRB7 plays a vital role in promoting the progression and mediating immune evasion of ovarian cancer. Pharmaceuticals (Basel), 2024; 17(8).","key":"4333_CR36","DOI":"10.3390\/ph17081043"},{"issue":"1","key":"4333_CR37","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/s41467-024-46283-y","volume":"15","author":"Z Ye","year":"2024","unstructured":"Ye Z, Xu S, Shi Y, et al. GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer. Nat Commun. 2024;15(1):2132.","journal-title":"Nat Commun"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04333-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04333-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04333-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:03:15Z","timestamp":1767034995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04333-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4333"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04333-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2269"}}